River Oaks Dental Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 20217 Ann Arbor Trl, Dearborn Hts, MI 48127 Phone: 313-928-3720 Fax: 313-274-7092 |
Dental Care Adults & Children Dentist Medicare: Not Enrolled in Medicare Practice Location: 24326 W Warren St, Dearborn Hts, MI 48127 Phone: 313-381-3850 Fax: 313-389-0046 |
Irving M Blau Dds & Richard A Kirsch Dds Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 24415 W Warren St, Dearborn Hts, MI 48127 Phone: 313-278-4470 Fax: 313-278-0124 |
Dr Beydoun And Associates, Inc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 24510 Ford Rd, Dearborn Hts, MI 48127 Phone: 313-561-2100 Fax: 313-561-1170 |
Jeffrey S Selasky, Dds, Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 25908 Ford Rd, Dearborn Hts, MI 48127 Phone: 313-277-0050 |
News Archive
Spectranetics Corporation today announced six month interim results from the PATENT (Photo-Ablation using the TURBO-Booster and Excimer Laser for In-Stent Restenosis Treatment) study evaluating the safety and efficacy of the Spectranetics peripheral laser atherectomy catheters for the treatment of in-stent restenosis (ISR) in the femoropopliteal artery in the leg.
There is a strong link between depression and anxiety disorders and autoimmune thyroiditis, a chronic thyroid condition affecting approximately 10 percent of the population. Scientists at Friedrich-Alexander-Universität Erlangen-Nürnberg have now proven that special treatment could help many sufferers, especially women.
NIEHS researchers analyzed dust samples, asked questions, and examined homes in the first National Survey of Lead and Allergens in Housing, a survey of 831 homes. Allergen levels were studied and related to demographic factors and household characteristics.
Skin cells typically spend their entire existence in one place on your body. But Washington State University researchers have seen how the cells will alter the proteins holding them in place and move to repair a wound.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Methylphenidate Transdermal System, 10 mg/9 hrs, 15 mg/9 hrs, 20 mg/9 hrs, and 30 mg/9 hrs.
› Verified 2 days ago